Indication

Vitreomacular adhesion

Vitreomacular adhesion is an ocular condition characterized by the incomplete posterior separation of the vitreous cortex from the retinal surface, where the vitreous body remains adherent to the macula within a 3-millimeter radius of the fovea. Read more about Vitreomacular adhesion

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Vitreomacular adhesion therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Vitreomacular adhesion preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Vitreomacular adhesion.

Vitreomacular adhesion is an ocular condition characterized by the incomplete posterior separation of the vitreous cortex from the retinal surface, where the vitreous body remains adherent to the macula within a 3-millimeter radius of the fovea.

Primarily affecting older adults experiencing age-related vitreous liquefaction, it represents an intermediate stage of posterior vitreous detachment.

In its strictly anatomic definition, the adhesion persists without causing structural distortion to the underlying retinal layers or foveal contour.

However, when associated with mechanical traction or recognized clinically as an indication for pharmacologic vitreolysis, persistent attachment exerts anteroposterior or tangential forces that can progress to vitreomacular traction, macular edema, or full-thickness macular holes.

Personalize your experience

Follow Vitreomacular adhesion and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it